PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2016

Anti-Inflammatory Effects of Rosiglitazone in Obesity-Impaired Wound Healing Depend on Adipocyte Differentiation.

Mouse / Wound

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 27992530 ↗2016Reported benefit

Anti-Inflammatory Effects of Rosiglitazone in Obesity-Impaired Wound Healing Depend on Adipocyte Differentiation.

MouseWoundC57Bl/6J-ob/ob (genetically obese) with wild-type C57Bl/6J as comparatorFemalen = Rosiglitazone wound analysis: wound tissue (three wounds pe…Oral gavage0.5 mg/kg/day, emulsified at 2 mg/mL in 0.5% TyloseTreatment started 2 days before wounding

Model: Six full-thickness excisional wounds, 5 mm in diameter and 3 to 4 mm apart, made on the back by excising skin and underlying panniculus carnosus under ketamine (80 mg/kg) and isoflurane anaesthesia

Oral rosiglitazone markedly improved the disturbed wound conditions in obese mice, giving complete re-epithelialisation and a collagen-enriched neo-dermis by day 13, a marked reduction in wound CXCL2 and cyclooxygenase-2 mRNA and protein, more regular subcutaneous adipocyte morphology, lower fastin…

Extraction: extract · Supplied extraction confidence: 0.9. Machine-extracted fields require source verification.